Shortages, Cost, and Frustration: Quest for the New COVID Shot

As the rollout of the newly formulated shot begins in earnest, many Americans are finding roadblocks.

Related Keywords

New Jersey ,United States ,New York ,Pennsylvania ,Americans ,American ,Mandy Cohen ,Matt Blanchette ,Xavier Becerra ,Dotty Johnson ,Levi Shaw Faber ,Dana Tofig ,Robert Hopkins Jr ,Zoe Cohen ,Eric Topol ,Scripps Research Translational Institute ,Us Department Of Health ,Medscape Coronavirus Resource Center ,Scripps Research Translational Institute In La Jolla ,Human Services ,National Foundation For Infectious Diseases ,National Infectious Disease Foundation ,Coronavirus Resource ,Human Services Secretary Xavier Becerra ,New York City ,National Foundation ,Covid 19 Vaccine ,Coronavirus Vaccine ,Vaccine ,Influenza ,Flu ,Health Insurance ,Insurance ,Biologic Therapy ,Practice Management ,Coronavirus ,019 Novel Coronavirus ,019 Ncov ,Uhan Coronavirus ,Uman Coronavirus Hku1 ,Uman Coronavirus Oc43 ,Cov Oc43 ,Uman Coronavirus 229e ,Cov 229e ,Pandemic ,Cancer ,Alignant Neoplasia ,Arcinoma ,Chemotherapy ,Cost Sharing ,Fatigue ,Geriatrics ,